05:52 PM EDT, 10/15/2024 (MT Newswires) -- Amir Nashat, 10% Owner, Director, on October 15, 2024, executed a purchase for 909,090 shares in Camp4 Therapeutics ( CAMP ) for $9,999,990. Following the Form 4 filing with the SEC, Nashat has control over a total of 909,090 shares of the company, with 909,090 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1736730/000110465924108703/xslF345X05/tm2426125-5_4seq1.xml